Ginkgo Bioworks Holdings (DNA) EPS (Weighted Average and Diluted): 2020-2025
Historic EPS (Weighted Average and Diluted) for Ginkgo Bioworks Holdings (DNA) over the last 5 years, with Sep 2025 value amounting to -$1.45.
- Ginkgo Bioworks Holdings' EPS (Weighted Average and Diluted) fell 34.26% to -$1.45 in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.19, marking a year-over-year increase of 52.05%. This contributed to the annual value of -$10.54 for FY2024, which is 42.62% up from last year.
- Latest data reveals that Ginkgo Bioworks Holdings reported EPS (Weighted Average and Diluted) of -$1.45 as of Q3 2025, which was down 31.82% from -$1.10 recorded in Q2 2025.
- Ginkgo Bioworks Holdings' 5-year EPS (Weighted Average and Diluted) high stood at -$0.06 for Q2 2021, and its period low was -$49.01 during Q4 2022.
- Moreover, its 3-year median value for EPS (Weighted Average and Diluted) was -$1.68 (2025), whereas its average is -$2.32.
- Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first spiked by 91.27% in 2023, then slumped by 4,600.00% in 2024.
- Over the past 5 years, Ginkgo Bioworks Holdings' EPS (Weighted Average and Diluted) (Quarterly) stood at -$1.21 in 2021, then slumped by 3,950.41% to -$49.01 in 2022, then surged by 91.27% to -$4.28 in 2023, then surged by 54.21% to -$1.96 in 2024, then crashed by 34.26% to -$1.45 in 2025.
- Its last three reported values are -$1.45 in Q3 2025, -$1.10 for Q2 2025, and -$1.68 during Q1 2025.